This pocket guide app is a resource and tools to on pathology and oncology perspectives in triple-negative breast cancer (TNBC). The original activity was presented by Dr. Ira Bleiweiss and Dr. Sara Tolaney. This app will provide expert insight into the roles of receptor and expression status in prognostication and treatment selection, pathological characteristics of different subtypes, incorporation of shared goals and biomarker testing into therapeutic selection, and strategies for recognizing and mitigating adverse events.
The app also contains
- Activity information
- Clinical Tools
- FAQs
- Links to resources
- and more!
Download the app today!
